Ronald J Vagnozzi1, Michelle A Sargent1, Suh-Chin J Lin1, Nathan J Palpant2, Charles E Murry3, Jeffery D Molkentin1,4. 1. Department of Pediatrics (R.J.V., M.A.S., S.-C.J.L., J.D.M.), Cincinnati Children's Hospital Medical Center, OH. 2. Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia (N.J.P.). 3. Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle (C.E.M.). 4. Howard Hughes Medical Institute (J.D.M.), Cincinnati Children's Hospital Medical Center, OH.
Abstract
BACKGROUND: The adult mammalian heart displays a cardiomyocyte turnover rate of ≈1%/y throughout postnatal life and after injuries such as myocardial infarction (MI), but the question of which cell types drive this low level of new cardiomyocyte formation remains contentious. Cardiac-resident stem cells marked by stem cell antigen-1 (Sca-1, gene name Ly6a) have been proposed as an important source of cardiomyocyte renewal. However, the in vivo contribution of endogenous Sca-1+ cells to the heart at baseline or after MI has not been investigated. METHODS: Here we generated Ly6a gene-targeted mice containing either a constitutive or an inducible Cre recombinase to perform genetic lineage tracing of Sca-1+ cells in vivo. RESULTS: We observed that the contribution of endogenous Sca-1+ cells to the cardiomyocyte population in the heart was <0.005% throughout all of cardiac development, with aging, or after MI. In contrast, Sca-1+ cells abundantly contributed to the cardiac vasculature in mice during physiological growth and in the post-MI heart during cardiac remodeling. Specifically, Sca-1 lineage-traced endothelial cells expanded postnatally in the mouse heart after birth and into adulthood. Moreover, pulse labeling of Sca-1+ cells with an inducible Ly6a-MerCreMer allele also revealed a preferential expansion of Sca-1 lineage-traced endothelial cells after MI injury in the mouse. CONCLUSIONS: Cardiac-resident Sca-1+ cells are not significant contributors to cardiomyocyte renewal in vivo. However, cardiac Sca-1+ cells represent a subset of vascular endothelial cells that expand postnatally with enhanced responsiveness to pathological stress in vivo.
BACKGROUND: The adult mammalian heart displays a cardiomyocyte turnover rate of ≈1%/y throughout postnatal life and after injuries such as myocardial infarction (MI), but the question of which cell types drive this low level of new cardiomyocyte formation remains contentious. Cardiac-resident stem cells marked by stem cell antigen-1 (Sca-1, gene name Ly6a) have been proposed as an important source of cardiomyocyte renewal. However, the in vivo contribution of endogenous Sca-1+ cells to the heart at baseline or after MI has not been investigated. METHODS: Here we generated Ly6a gene-targeted mice containing either a constitutive or an inducible Cre recombinase to perform genetic lineage tracing of Sca-1+ cells in vivo. RESULTS: We observed that the contribution of endogenous Sca-1+ cells to the cardiomyocyte population in the heart was <0.005% throughout all of cardiac development, with aging, or after MI. In contrast, Sca-1+ cells abundantly contributed to the cardiac vasculature in mice during physiological growth and in the post-MI heart during cardiac remodeling. Specifically, Sca-1 lineage-traced endothelial cells expanded postnatally in the mouse heart after birth and into adulthood. Moreover, pulse labeling of Sca-1+ cells with an inducible Ly6a-MerCreMer allele also revealed a preferential expansion of Sca-1 lineage-traced endothelial cells after MI injury in the mouse. CONCLUSIONS: Cardiac-resident Sca-1+ cells are not significant contributors to cardiomyocyte renewal in vivo. However, cardiac Sca-1+ cells represent a subset of vascular endothelial cells that expand postnatally with enhanced responsiveness to pathological stress in vivo.
Authors: Thomas Eschenhagen; Roberto Bolli; Thomas Braun; Loren J Field; Bernd K Fleischmann; Jonas Frisén; Mauro Giacca; Joshua M Hare; Steven Houser; Richard T Lee; Eduardo Marbán; James F Martin; Jeffery D Molkentin; Charles E Murry; Paul R Riley; Pilar Ruiz-Lozano; Hesham A Sadek; Mark A Sussman; Joseph A Hill Journal: Circulation Date: 2017-07-06 Impact factor: 29.690
Authors: W L Stanford; S Haque; R Alexander; X Liu; A M Latour; H R Snodgrass; B H Koller; P M Flood Journal: J Exp Med Date: 1997-08-29 Impact factor: 14.307
Authors: Samuel E Senyo; Matthew L Steinhauser; Christie L Pizzimenti; Vicky K Yang; Lei Cai; Mei Wang; Ting-Di Wu; Jean-Luc Guerquin-Kern; Claude P Lechene; Richard T Lee Journal: Nature Date: 2012-12-05 Impact factor: 49.962
Authors: Jop H van Berlo; Onur Kanisicak; Marjorie Maillet; Ronald J Vagnozzi; Jason Karch; Suh-Chin J Lin; Ryan C Middleton; Eduardo Marbán; Jeffery D Molkentin Journal: Nature Date: 2014-05-07 Impact factor: 49.962
Authors: Kalpaj R Parekh; Janna Nawroth; Albert Pai; Shana M Busch; Christiana N Senger; Amy L Ryan Journal: Am J Physiol Cell Physiol Date: 2020-08-12 Impact factor: 4.249
Authors: José A Gomez; Alan Payne; Richard E Pratt; Conrad P Hodgkinson; Victor J Dzau Journal: Proc Natl Acad Sci U S A Date: 2021-08-17 Impact factor: 11.205
Authors: Alexander Vesprey; Eun Sung Suh; Didem Göz Aytürk; Xu Yang; Miracle Rogers; Branden Sosa; Yingzhen Niu; Ivo Kalajzic; Lionel B Ivashkiv; Mathias Pg Bostrom; Ugur M Ayturk Journal: J Bone Miner Res Date: 2021-02-26 Impact factor: 6.741